Severe hypercalcemia in a patient treated for hypoparathyroidism with calcitriol

Pediatric Endocrinology Reviews

Volumn 7, Issue 4, 2010, Pages 363-365

  De Sanctis, Vincenzo ^a   Fiscina, Bernadette ^b   Ciccone, Sara ^c  

^a Pediatric and Adolescent Unit   (Italy)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE

Author keywords

Calcitriol; Hypercalcemia; Hypoparathyroidism; Thalassaemia

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; CALCITONIN; CALCITRIOL; CALCIUM; CREATININE; DEFEROXAMINE MESYLATE; FERRITIN; FUROSEMIDE; GLUCOSE; HEMOGLOBIN; LEVOTHYROXINE; MAGNESIUM; PARATHYROID HORMONE; PHOSPHORUS; PREDNISONE;

ADOLESCENT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; CASE REPORT; CREATININE BLOOD LEVEL; DIET SUPPLEMENTATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; FERRITIN BLOOD LEVEL; FOLLOW UP; GLUCOSE BRAIN LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERCALCEMIA; HYPOPARATHYROIDISM; IRON CHELATION; IRON OVERLOAD; LONG TERM CARE; MAGNESIUM BLOOD LEVEL; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; REHYDRATION; THALASSEMIA; BLOOD; CHEMICALLY INDUCED DISORDER;

ADOLESCENT; CALCITONIN; CALCITRIOL; FUROSEMIDE; HUMANS; HYPERCALCEMIA; HYPOPARATHYROIDISM; MALE; PREDNISONE;

EID: 77956089422     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. De Luca HF. New developments in vitamin D endocrine system. J Am Diet Assoc 1982;80:231-237
2. Martin TJ, Griel V. Hypercalcemia. Clin Endocrinol 1995;42:535-538
3. Bilezikian JP. Management of acute hypercalcemia. New Engl J Med 1992;328:1196-1203
4. Carroll MF, Shade DS. A practical approach to hypercalcemia. Am Fam Phys 2003;67:1959-1966 (Pubitemid 36554449)
5. Jaaskelainen J, Perheentupa J. Autoimmune polyendocrinopathy-candidosis · ectodermal dystrophy (APECED) - a diagnostic and therapeutic challenge. Ped Endocrinol Rev 2009;7:15-28
6. Laubenthal F, Reichenberger M, Reinwein D. Fatal vitamin D intoxication. Deutsch Med Wochenschr 1975;100:412-415
7. Pratelli L, Verri E, Fortini M, Marconi S, Zolezzi C, Fornasari PM, Gamberini MR, De Sanctis V. Chelation therapy and bone metabolism markers in thalassaemia major. J Clin Endocrinol Metab 2006;19:1335-1342 (Pubitemid 44963844)
8. De Sanctis V, Vullo C, Bagni B, Chiccali L. Hypoparathyroidism in beta-thalassemia major. Clinical and laboratory observations in 24 patients. Acta Haematolol 1992;88:105-108 (Pubitemid 23002594)
9. Karimi M, Habibzadeh F, De Sanctis V. Hypoparathyroidism with extensive intracerebral calcification in patients with beta-thalassemia major. J Pediatr Endocrinol Metab 2003;16:883-886. (Pubitemid 37259175)
10. Zamboni G, Marradi P, Tagliaro F, Dorizzi R, Tató L. Parathyroid hormone, calcitonin and vitamin D metabolites in beta-thalassaemia major. Eur J Pediatr 1986;145:133-136 (Pubitemid 16097689)
11. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999; 69:842-856 (Pubitemid 29205056)
12. Maeda SS, Fortes EM, Oliveira UM, Borba VC, Lazaretti-Castro M. Hypoparathyroidism and pseudohypoparathyroidism. Arq Bras Endocrinol Metabol 2006;50:664-673 (Pubitemid 44786003)
13. Chan JCM, Young RB, Alon U, Mamunes P. Hypercalcemia in children with disorders of calcium and phosphate metabolism during long-term treatment with 1,25-dihydroxyvitamin-D3. Pediatrics 1983;72:225-233 (Pubitemid 13030220)
14. Lafferty FW. Differential diagnosis of hypercalcemia. J Bone Miner Res 1991;6(suppl 2):S51-S59
15. Pettifor JM, Bikle DD, Cavaleros M, Zachen D, Kamdar MC, Ross FP. Serum levels of free 1,25-dihydroxyvitamin D in vitamin D toxicity. Ann Intern Med 1995;122:511-513
16. Hoeck HC, Laurberg G, Laurberg P. Hypercalcaemic crisis after excessive topical use of vitamin D derivates. J Intern Med 1994;235:281-282 (Pubitemid 24210836)
17. Lapatsanis P, Sbyrakis S, Vretos C, Karaklis A, Doxiadis S. Phosphaturia in thalassemia. Pediatrics 1976;58:885-892 (Pubitemid 8000150)